 | • レポートコード：B-GIR09D2832 • 出版社/出版日：GlobalInfoResearch / 2019年9月11日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、123ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、乾癬性関節炎治療薬の世界市場について調べ、まとめました。種類別セグメントは、NF阻害剤、インターロイキン阻害剤、PDE4阻害剤、その他等、用途別セグメントは、病院薬局、小売薬局、オンライン薬局等に区分しました。乾癬性関節炎治療薬の世界市場概観、メーカー動向、メーカー別乾癬性関節炎治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・乾癬性関節炎治療薬の市場概観 ・乾癬性関節炎治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・乾癬性関節炎治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・乾癬性関節炎治療薬の世界市場規模 ・乾癬性関節炎治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・乾癬性関節炎治療薬のアメリカ市場規模推移 ・乾癬性関節炎治療薬のカナダ市場規模推移 ・乾癬性関節炎治療薬のメキシコ市場規模推移 ・乾癬性関節炎治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・乾癬性関節炎治療薬のドイツ市場規模推移 ・乾癬性関節炎治療薬のイギリス市場規模推移 ・乾癬性関節炎治療薬のロシア市場規模推移 ・乾癬性関節炎治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・乾癬性関節炎治療薬の日本市場規模推移 ・乾癬性関節炎治療薬の中国市場規模推移 ・乾癬性関節炎治療薬の韓国市場規模推移 ・乾癬性関節炎治療薬のインド市場規模推移 ・乾癬性関節炎治療薬の東南アジア市場規模推移 ・乾癬性関節炎治療薬の南米市場分析（ブラジル、アルゼンチン等） ・乾癬性関節炎治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・乾癬性関節炎治療薬の種類別分析/販売量、売上、市場シェア（NF阻害剤、インターロイキン阻害剤、PDE4阻害剤、その他） ・乾癬性関節炎治療薬の用途別分析/市場規模（病院薬局、小売薬局、オンライン薬局） ・乾癬性関節炎治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・乾癬性関節炎治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Psoriatic arthritis is a chronic autoimmune inflammatory disorder that causes inflammation, swelling, and stiffness at any joint of the body. Psoriatic arthritis is a progressive form of psoriasis, characterized by the itchy, scaly red patches on the skin.
Scope of the Report:
Asia Pacific is anticipated to dominate the global market over the forecast period owing to its high demand in the region.
The worldwide market for Psoriatic Arthritis Therapeutics Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Psoriatic Arthritis Therapeutics Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
AbbVie
Janssen Biotech
Novartis
Amgen
CELGENE CORPORATION
Pfizer
Eli Lilly
UCB
Biogen
Bristol-Myers Squibb
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
NF Inhibitors
Interleukin Inhibitors
PDE4 Inhibitors
Others
Market Segment by Applications, can be divided into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Psoriatic Arthritis Therapeutics Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Psoriatic Arthritis Therapeutics Drug, with price, sales, revenue and global market share of Psoriatic Arthritis Therapeutics Drug in 2017 and 2018.
Chapter 3, the Psoriatic Arthritis Therapeutics Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Psoriatic Arthritis Therapeutics Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Psoriatic Arthritis Therapeutics Drug market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Psoriatic Arthritis Therapeutics Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Psoriatic Arthritis Therapeutics Drug Introduction
1.2 Market Analysis by Type
1.2.1 NF Inhibitors
1.2.2 Interleukin Inhibitors
1.2.3 PDE4 Inhibitors
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Hospital Pharmacies
1.3.2 Retail Pharmacies
1.3.3 Online Pharmacies
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 AbbVie
2.1.1 Business Overview
2.1.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Janssen Biotech
2.2.1 Business Overview
2.2.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Novartis
2.3.1 Business Overview
2.3.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Novartis Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Amgen
2.4.1 Business Overview
2.4.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Amgen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 CELGENE CORPORATION
2.5.1 Business Overview
2.5.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Pfizer
2.6.1 Business Overview
2.6.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Eli Lilly
2.7.1 Business Overview
2.7.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 UCB
2.8.1 Business Overview
2.8.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 UCB Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Biogen
2.9.1 Business Overview
2.9.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Biogen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Bristol-Myers Squibb
2.10.1 Business Overview
2.10.2 Psoriatic Arthritis Therapeutics Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Psoriatic Arthritis Therapeutics Drug Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Psoriatic Arthritis Therapeutics Drug Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Psoriatic Arthritis Therapeutics Drug Manufacturer Market Share in 2018
3.3.2 Top 6 Psoriatic Arthritis Therapeutics Drug Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Psoriatic Arthritis Therapeutics Drug Market Analysis by Regions
4.1 Global Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales and Market Share by Regions (2014-2019)
4.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Regions (2014-2019)
4.2 North America Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
4.3 Europe Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
4.5 South America Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
5 North America Psoriatic Arthritis Therapeutics Drug by Country
5.1 North America Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Market Share by Country
5.1.1 North America Psoriatic Arthritis Therapeutics Drug Sales and Market Share by Country (2014-2019)
5.1.2 North America Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Country (2014-2019)
5.2 United States Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
5.3 Canada Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
5.4 Mexico Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
6 Europe Psoriatic Arthritis Therapeutics Drug by Country
6.1 Europe Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Psoriatic Arthritis Therapeutics Drug Sales and Market Share by Country (2014-2019)
6.1.2 Europe Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Country (2014-2019)
6.2 Germany Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
6.3 UK Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
6.4 France Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
6.5 Russia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
6.6 Italy Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
7 Asia-Pacific Psoriatic Arthritis Therapeutics Drug by Country
7.1 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Country (2014-2019)
7.2 China Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
7.3 Japan Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
7.4 Korea Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
7.5 India Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
8 South America Psoriatic Arthritis Therapeutics Drug by Country
8.1 South America Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Market Share by Country
8.1.1 South America Psoriatic Arthritis Therapeutics Drug Sales and Market Share by Country (2014-2019)
8.1.2 South America Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Country (2014-2019)
8.2 Brazil Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
8.3 Argentina Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
8.4 Colombia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
9 Middle East and Africa Psoriatic Arthritis Therapeutics Drug by Countries
9.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
9.3 Turkey Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
9.4 Egypt Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
9.5 Nigeria Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
9.6 South Africa Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
10 Global Psoriatic Arthritis Therapeutics Drug Market Segment by Type
10.1 Global Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Psoriatic Arthritis Therapeutics Drug Sales and Market Share by Type (2014-2019)
10.1.2 Global Psoriatic Arthritis Therapeutics Drug Revenue and Market Share by Type (2014-2019)
10.2 NF Inhibitors Sales Growth and Price
10.2.1 Global NF Inhibitors Sales Growth (2014-2019)
10.2.2 Global NF Inhibitors Price (2014-2019)
10.3 Interleukin Inhibitors Sales Growth and Price
10.3.1 Global Interleukin Inhibitors Sales Growth (2014-2019)
10.3.2 Global Interleukin Inhibitors Price (2014-2019)
10.4 PDE4 Inhibitors Sales Growth and Price
10.4.1 Global PDE4 Inhibitors Sales Growth (2014-2019)
10.4.2 Global PDE4 Inhibitors Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Psoriatic Arthritis Therapeutics Drug Market Segment by Application
11.1 Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Application (2014-2019)
11.2 Hospital Pharmacies Sales Growth (2014-2019)
11.3 Retail Pharmacies Sales Growth (2014-2019)
11.4 Online Pharmacies Sales Growth (2014-2019)
12 Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
12.1 Global Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Growth Rate (2019-2024)
12.2 Psoriatic Arthritis Therapeutics Drug Market Forecast by Regions (2019-2024)
12.2.1 North America Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
12.2.2 Europe Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
12.2.3 Asia-Pacific Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
12.2.4 South America Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
12.2.5 Middle East and Africa Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
12.3 Psoriatic Arthritis Therapeutics Drug Market Forecast by Type (2019-2024)
12.3.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Type (2019-2024)
12.3.2 Global Psoriatic Arthritis Therapeutics Drug Market Share Forecast by Type (2019-2024)
12.4 Psoriatic Arthritis Therapeutics Drug Market Forecast by Application (2019-2024)
12.4.1 Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Application (2019-2024)
12.4.2 Global Psoriatic Arthritis Therapeutics Drug Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Psoriatic Arthritis Therapeutics Drug Picture
Table Product Specifications of Psoriatic Arthritis Therapeutics Drug
Figure Global Sales Market Share of Psoriatic Arthritis Therapeutics Drug by Types in 2018
Table Psoriatic Arthritis Therapeutics Drug Types for Major Manufacturers
Figure NF Inhibitors Picture
Figure Interleukin Inhibitors Picture
Figure PDE4 Inhibitors Picture
Figure Others Picture
Figure Psoriatic Arthritis Therapeutics Drug Sales Market Share by Applications in 2018
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Online Pharmacies Picture
Figure United States Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure France Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure UK Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure China Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure India Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Psoriatic Arthritis Therapeutics Drug Revenue (Value) and Growth Rate (2014-2024)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Psoriatic Arthritis Therapeutics Drug Type and Applications
Table AbbVie Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Janssen Biotech Basic Information, Manufacturing Base and Competitors
Table Janssen Biotech Psoriatic Arthritis Therapeutics Drug Type and Applications
Table Janssen Biotech Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Psoriatic Arthritis Therapeutics Drug Type and Applications
Table Novartis Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Psoriatic Arthritis Therapeutics Drug Type and Applications
Table Amgen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table CELGENE CORPORATION Basic Information, Manufacturing Base and Competitors
Table CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Type and Applications
Table CELGENE CORPORATION Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Psoriatic Arthritis Therapeutics Drug Type and Applications
Table Pfizer Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Psoriatic Arthritis Therapeutics Drug Type and Applications
Table Eli Lilly Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table UCB Basic Information, Manufacturing Base and Competitors
Table UCB Psoriatic Arthritis Therapeutics Drug Type and Applications
Table UCB Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Biogen Basic Information, Manufacturing Base and Competitors
Table Biogen Psoriatic Arthritis Therapeutics Drug Type and Applications
Table Biogen Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Type and Applications
Table Bristol-Myers Squibb Psoriatic Arthritis Therapeutics Drug Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Psoriatic Arthritis Therapeutics Drug Sales by Manufacturer (2017-2018)
Figure Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturer in 2017
Figure Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Manufacturer in 2018
Table Global Psoriatic Arthritis Therapeutics Drug Revenue by Manufacturer (2017-2018)
Figure Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturer in 2017
Figure Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Manufacturer in 2018
Figure Top 3 Psoriatic Arthritis Therapeutics Drug Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Psoriatic Arthritis Therapeutics Drug Manufacturer (Revenue) Market Share in 2018
Figure Global Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Global Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Sales by Regions (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Sales Market Share by Regions (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Revenue by Regions (2014-2019)
Figure Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Regions in 2014
Figure Global Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Regions in 2018
Figure North America Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Europe Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure South America Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure North America Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2014-2019)
Table North America Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019)
Table North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019)
Figure North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries in 2014
Figure North America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries in 2018
Table North America Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019)
Table North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries (2014-2019)
Figure North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries in 2014
Figure North America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries in 2018
Figure United States Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Canada Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Mexico Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Europe Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2014-2019)
Table Europe Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019)
Table Europe Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019)
Table Europe Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019)
Figure Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries in 2017
Figure Europe Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries in 2018
Figure Germany Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure UK Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure France Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Russia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Italy Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019)
Table Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries 2018
Table Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019)
Figure Asia-Pacific Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries 2018
Figure China Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Japan Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Korea Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure India Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Southeast Asia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure South America Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2014-2019)
Table South America Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019)
Table South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019)
Figure South America Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries in 2018
Table South America Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019)
Table South America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries (2014-2019)
Figure South America Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries in 2018
Figure Brazil Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Argentina Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Colombia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales by Countries (2014-2019)
Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Sales Market Share by Countries in 2018
Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue by Countries (2014-2019)
Table Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries in 2014
Figure Middle East and Africa Psoriatic Arthritis Therapeutics Drug Revenue Market Share by Countries in 2018
Figure Saudi Arabia Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure UAE Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Egypt Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure Nigeria Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Figure South Africa Psoriatic Arthritis Therapeutics Drug Sales and Growth Rate (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Sales by Type (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Sales Share by Type (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Revenue by Type (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Revenue Share by Type (2014-2019)
Figure Global NF Inhibitors Sales Growth (2014-2019)
Figure Global NF Inhibitors Price (2014-2019)
Figure Global Interleukin Inhibitors Sales Growth (2014-2019)
Figure Global Interleukin Inhibitors Price (2014-2019)
Figure Global PDE4 Inhibitors Sales Growth (2014-2019)
Figure Global PDE4 Inhibitors Price (2014-2019)
Figure Global Others Sales Growth (2014-2019)
Figure Global Others Price (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Sales by Application (2014-2019)
Table Global Psoriatic Arthritis Therapeutics Drug Sales Share by Application (2014-2019)
Figure Global Retail Pharmacies Sales Growth (2014-2019)
Figure Global Online Pharmacies Sales Growth (2014-2019)
Figure Global Psoriatic Arthritis Therapeutics Drug Sales, Revenue and Growth Rate (2019-2024)
Table Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Regions (2019-2024)
Table Global Psoriatic Arthritis Therapeutics Drug Market Share Forecast by Regions (2019-2024)
Figure North America Sales Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
Figure Europe Sales Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
Figure Asia-Pacific Sales Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
Figure South America Sales Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
Figure Middle East and Africa Sales Psoriatic Arthritis Therapeutics Drug Market Forecast (2019-2024)
Table Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Type (2019-2024)
Table Global Psoriatic Arthritis Therapeutics Drug Market Share Forecast by Type (2019-2024)
Table Global Psoriatic Arthritis Therapeutics Drug Sales Forecast by Application (2019-2024)
Table Global Psoriatic Arthritis Therapeutics Drug Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界のCox-2阻害剤市場予測（～2024年） Cox-2 Inhibitors are a type of nonsteroidal anti-inflammatory drug (NSAID) that directly targets cyclooxygenase-2, Cox-2, an enzyme responsible for inflammation and pain. These drugs are responsible for decreasing the production of prostaglandins. Scope of the Report: The global Cox-2 Inhibitors mar…- インターロイキン阻害剤市場：世界及び中国市場分析・予測（～2024年） Interleukin Inhibitors Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Interleukin Inhibitors industry with a focus on the Chinese market. The report provides key statistics on the market status of the Interleukin Inhibitors m…
- 乾癬性関節炎治療薬市場：世界及び中国市場分析・予測（～2024年） Psoriatic Arthritis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Psoriatic Arthritis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Psoriatic Arthritis …
- 世界の炎症性皮膚疾患薬市場予測（～2024年） Scope of the Report: The global Inflammatory Skin Diseases Drugs market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in…
- 世界の炎症性皮膚疾患治療市場予測（～2024年） Scope of the Report: The global Inflammatory Skin Diseases Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especiall…